BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24732412)

  • 1. Potential drug interactions with melatonin.
    Papagiannidou E; Skene DJ; Ioannides C
    Physiol Behav; 2014 May; 131():17-24. PubMed ID: 24732412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices.
    Skene DJ; Papagiannidou E; Hashemi E; Snelling J; Lewis DF; Fernandez M; Ioannides C
    J Pineal Res; 2001 Nov; 31(4):333-42. PubMed ID: 11703563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.
    Härtter S; Wang X; Weigmann H; Friedberg T; Arand M; Oesch F; Hiemke C
    J Clin Psychopharmacol; 2001 Apr; 21(2):167-74. PubMed ID: 11270913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Methoxypsoralen inhibits 6-hydroxylation of melatonin in the rat.
    Mauviard F; Raynaud F; Geoffriau M; Claustrat B; Pévet P
    Biol Signals; 1995; 4(1):32-41. PubMed ID: 7550582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 6-hydroxymelatonin, 6-sulfatoxymelatonin and melatonin kinetics after melatonin administration to rats.
    Raynaud F; Mauviard F; Geoffriau M; Claustrat B; Pevet P
    Biol Signals; 1993; 2(6):358-66. PubMed ID: 8038864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response.
    Konstandi M; Segos D; Galanopoulou P; Theocharis S; Zarros A; Lang MA; Marselos M; Liapi C
    J Appl Toxicol; 2009 Mar; 29(2):101-9. PubMed ID: 18798224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
    Zhao XJ; Ishizaki T
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2.
    Kast RE; Altschuler EL
    Med Hypotheses; 2006; 67(6):1389-90. PubMed ID: 16893613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics.
    Obach RS; Ryder TF
    Drug Metab Dispos; 2010 Aug; 38(8):1381-91. PubMed ID: 20478852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorpromazine inhibition of melatonin metabolism by normal and induced rat liver microsomes.
    Beedham C; Smith JA; Steele DL; Wright PA
    Eur J Drug Metab Pharmacokinet; 1987; 12(4):299-302. PubMed ID: 3449389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle.
    Sakano K; Oikawa S; Hiraku Y; Kawanishi S
    Biochem Pharmacol; 2004 Nov; 68(9):1869-78. PubMed ID: 15450952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
    Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
    J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro.
    Feierman DE
    Acta Anaesthesiol Scand; 2000 May; 44(5):560-3. PubMed ID: 10786743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
    Feuer G
    Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent.
    Nicolas JM; Collart P; Gerin B; Mather G; Trager W; Levy R; Roba J
    Drug Metab Dispos; 1999 Feb; 27(2):250-4. PubMed ID: 9929511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of melatonin on ascorbate-Fe2+ lipid peroxidation of polyunsaturated fatty acids in rat liver, kidney and brain microsomes: a chemiluminescence study.
    Leaden PJ; Catalá A
    J Pineal Res; 2005 Sep; 39(2):164-9. PubMed ID: 16098094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.